Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery

Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery

Trypanosoma brucei (T. brucei) is the causative agent of the Human African Trypanosomiasis (HAT), which is a neglected disease with an endemic occurrence in 36 sub-Saharan African countries. The current standard of care suffers from low efficacy and severe side effects. Therefore, new drugs with bet...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkki: Münzker Lena
Eará dahkkit: Klebe, Gerhard (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Materiálatiipa: Dissertation
Giella:eaŋgalasgiella
Almmustuhtton: Philipps-Universität Marburg 2019
Fáttát:
Pharmakologie, Therapeutik
Farnesylpyrophosphat-Synthase
Trypanosoma brucei
Fragment-basierte Wirkstoffentwicklung
farnesyl pyrophosphate synthase
Fragment-based drug discovery
Pharmacology & therapeutics, prescription drugs
Liŋkkat:PDF-ollesdeaksta
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid